The brain and nervous system rely on healthy neurons to transmit signals that control movement, balance, behavior, learning, and sensory perception. In dogs affected by DE, genetic mutations disrupt normal cellular processes within nerve cells, causing progressive damage and loss of neurological function. As nerve cells deteriorate, communication between the brain and body becomes increasingly impaired, resulting in a wide range of neurological symptoms.
Clinical signs of Degenerative Encephalopathy often begin during puppyhood or early adulthood, although the age of onset and severity may vary depending on the specific mutation involved. Early symptoms can be subtle and may include mild coordination problems, unusual behavior, reduced responsiveness, or difficulty learning new tasks. As the disease progresses, affected dogs may develop an unsteady gait, loss of balance, tremors, muscle weakness, stumbling, difficulty walking, and impaired coordination. Some dogs may also experience vision abnormalities, behavioral changes, seizures, or cognitive decline. In advanced stages, severe neurological impairment can significantly affect mobility and daily functioning.
The DE DNA Health Test is designed to identify the specific genetic mutation associated with Degenerative Encephalopathy. Testing is simple, safe, and non-invasive, requiring either a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine the dog's genetic status. Because DNA remains unchanged throughout life, testing can be performed at any age, including in puppies before clinical signs become apparent.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the DE mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically unaffected by the disease. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Degenerative Encephalopathy during its lifetime.
Genetic testing for DE provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disorder while preserving healthy genetic diversity within the breed population. Avoiding the breeding of two carrier dogs significantly decreases the risk of producing affected puppies.
For dog owners, knowledge of a dog's genetic status allows for proactive neurological monitoring and early veterinary evaluation. Dogs identified as at risk may benefit from regular neurological examinations and supportive care designed to maintain comfort and quality of life. While there is currently no cure for Degenerative Encephalopathy, early diagnosis can help guide management strategies and prepare owners for potential future health challenges.
The Degenerative Encephalopathy (DE) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this inherited neurodegenerative disorder in future generations. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
